CFTC to Judge: CME’s Perpetual Futures Lawsuit Is ‘Much Ado About Nothing’

So the CFTC just told a federal judge that CME’s lawsuit over perpetual futures is essentially a waste of time. And they’ve got a point. The regulator’s motion to dismiss, filed this week in the Northern District of Illinois, doesn’t mince words: the whole thing is “much ado about nothing.”

The dispute started when CME sued the CFTC in December, arguing that the agency’s 2023 order on perpetual futures effectively banned the exchange from listing these products. CME claimed the order was arbitrary and capricious, that it gave unfair advantage to offshore competitors like Binance and Bybit. But the CFTC’s latest filing says CME is misreading the order entirely. The order, they argue, actually allows any designated contract market, CME included, to list perpetual futures, as long as they follow the same rules that apply to traditional futures.

Let’s be clear: this isn’t some esoteric regulatory spat. Perpetual futures, or “perps” as traders call them, are the backbone of crypto derivatives trading. They’re futures contracts with no expiration date, funded by a periodic funding rate that keeps the contract price tethered to the spot price. They’re how most of the leverage in crypto gets deployed. The global daily volume in bitcoin perpetuals alone regularly tops $20 billion, according to data from CoinGecko. That’s more than the entire spot market for most assets.

So when the biggest U.S. futures exchange sues the primary derivatives regulator over the right to list these products, it matters. But the CFTC’s latest filing suggests the battle might be over before it really began.

The Lawsuit: A Quick Recap

CME filed its complaint last December, after the CFTC issued a staff letter in 2023 that clarified how perpetual futures fit within the existing Commodity Exchange Act framework. The letter said that perpetual futures are futures contracts, full stop. That means they fall under the same rules: must be traded on a designated contract market (DCM) or a swap execution facility (SEF), subject to position limits, reporting, all of it.

CME’s argument was that this classification effectively banned the product because the rules for DCMs require daily settlement and delivery, which perpetuals don’t have. But the CFTC says that’s a misinterpretation. The order, they note, explicitly allows DCMs to list perpetuals if they meet certain conditions, like ensuring the funding rate mechanism doesn’t create a cash-settled swap that would require different treatment.

In other words, CME could have listed perpetuals all along. They just didn’t bother to apply. The CFTC’s motion calls the lawsuit “a challenge to an interpretation that does not exist.” Ouch.

Why the CFTC Says It’s Much Ado About Nothing

The phrase “much ado about nothing” is a direct quote from the CFTC’s brief. And it’s not just rhetorical flair. The regulator’s legal argument is straightforward: the 2023 staff letter didn’t change the law. It merely restated existing rules and showed how they apply to a new product structure. CME, they say, is trying to manufacture a controversy where none exists.

Look, I’ve covered enough regulatory fights to know that agencies rarely use Shakespearean put-downs in court filings unless they’re confident. The CFTC’s motion leans hard on the idea that CME is complaining about a restriction that doesn’t actually restrict them. “If CME wishes to list perpetual futures,” the brief states, “it may do so.” Full stop.

That’s a big deal for the market. If the judge agrees, and motions to dismiss are often granted when the plaintiff lacks standing or the claim is moot, then the path is clear for CME to launch bitcoin and ether perpetuals. And that would be a seismic shift for institutional crypto derivatives.

Right now, the vast majority of perpetual futures trading happens on offshore exchanges like Binance, OKX, and Bybit. Those platforms aren’t registered with the CFTC, which means U.S. institutions can’t touch them. If CME lists perps, it opens the door for pension funds, hedge funds, and asset managers to trade these products in a regulated environment. That could pull billions of dollars onshore.

What This Means for Crypto Derivatives

The immediate read: if the lawsuit is dismissed, CME will likely move quickly to list perpetuals. They already have the infrastructure, their existing bitcoin and ether futures are among the most liquid in the world. Adding a perpetual version is mostly a matter of tweaking the contract specs and funding rate mechanism.

But here’s the thing: CME’s lawsuit might not have been about actually getting permission to list perps. It might have been about forcing the CFTC to clarify the rules. And in that sense, it’s already worked. The agency’s motion to dismiss is, paradoxically, the clearest statement yet that perpetuals are welcome on U.S. exchanges.

The bigger picture is regulatory competition. The U.S. has been losing crypto derivatives volume to offshore venues for years. The CFTC knows this. Chairman Rostin Behnam has said repeatedly that he wants to bring crypto trading into the regulated fold. This filing is consistent with that agenda. It’s a signal to exchanges: stop waiting for permission, just comply with the rules.

For traders, the implications are practical. A CME perpetual product would mean tighter spreads, deeper liquidity, and the ability to do basis trades without needing to use offshore platforms. The cash-and-carry trade, long spot, short futures, has been a staple for crypto arb funds. Perpetuals make that trade even more efficient because there’s no roll cost. If CME lists them, expect a wave of institutional arbitrage capital to enter the market.

And that flows into the broader institutional adoption story. Just last month, XRP ETFs pulled in $170 million in 11 days, with Goldman Sachs among the top holders. The demand for regulated crypto exposure is real. Perpetual futures are the next logical step.

The Bigger Picture: Regulatory Clarity or Confusion?

But let’s not get ahead of ourselves. The lawsuit isn’t dismissed yet. CME could push back, and the judge could let the case proceed. Even if it’s dismissed, the underlying question, how do perpetuals fit into a legal framework designed for traditional futures, isn’t fully settled. The CFTC’s staff letter is guidance, not a rule. A future administration could reverse it.

And there’s the jurisdictional fight with the SEC. Perpetual futures on crypto tokens that might be securities (like ether before the Merge) could fall under SEC jurisdiction. The CFTC’s motion doesn’t address that. So while this particular lawsuit might be much ado about nothing, the broader regulatory picture is still a mess.

Still, for anyone trading crypto derivatives, this is a positive development. The CFTC is essentially saying: bring it on. The ball is now in CME’s court. Do they really want to list perps, or was the lawsuit just a negotiating tactic? My bet is they’ll move fast. The revenue potential is enormous, think about the fees on $20 billion of daily volume, even at a fraction of a basis point.

And if they don’t, someone else will. The CFTC has made it clear that any DCM can list these products. That includes smaller exchanges like ErisX or Bakkt. The race is on.

One final note: this whole episode shows why the regulatory process for new financial products is often more about politics than law. CME could have asked for a no-action letter or a formal rulemaking. Instead, they sued. The CFTC could have issued a more explicit rule years ago. Instead, they wrote a staff letter. Both sides were playing a game of chicken. Now we know who blinked first.

The next move belongs to the judge. But if the CFTC’s motion is granted, expect CME perpetual futures within months. And expect the rest of the market to follow.